deltatrials
Completed OBSERVATIONAL NCT01325064

Blood Pressure and Subclinical Organ Damage (Vasorisk)

Central and Peripheral Blood Pressure and Its Relation With Vascular Target Organ Damage in Carotid, Retinal and Arterial Stiffness. Developed and Validation of a Tool

Sponsor: Carlos III Health Institute

Updated 8 times since 2017 Last updated: Feb 20, 2020 Started: Jun 30, 2010 Primary completion: Dec 31, 2010 Completion: Dec 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Diabetes Mellitus and is currently completed. Carlos III Health Institute leads this study, which shows 8 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Mar 2017 · 59 days · monthly snapshotUnknown Status~Mar 2017 – ~Apr 2018 · 13 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Mar 2020 · 21 months · monthly snapshotCompleted~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Mar 2020 — Jan 2021 [monthly]

    Completed

  5. Jun 2018 — Mar 2020 [monthly]

    Completed

Show 3 earlier versions
  1. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

  2. Mar 2017 — Apr 2018 [monthly]

    Completed NA

    Status: Unknown StatusCompleted

  3. Jan 2017 — Mar 2017 [monthly]

    Unknown Status NA

    First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Carlos III Health Institute
  • Castilla-León Health Service
  • Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Data source: Fundacion para la Investigacion y Formacion en Ciencias de la Salud

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations